Skip to search formSkip to main contentSkip to account menu

Hivid

Known as: HIVID Roche, Hoffman-La Roche Brand of Zalcitabine, Roche Brand of Zalcitabine 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (5)

2',3'-DideoxynucleosidesAnti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors

Narrower (6)

2',3'-dideoxycytidineneBCH-189CS-92Epivir
BW 524W91Racivir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The Preparedness of national secondary school teachers in Nairobi Province to implement HIV/AIDS Education curriculum
xv 
2002
2002
Availability of Hivid
It has been brought to my attention that many HIV treating clinicians believe that zalcitabine (Hivid) has been taken off the… 
Review
2002
Review
2002
Handbook of HIV Medicine, Douglas Wilson, Sudeshni Naidoo, Linda-Gail Bekker, Mark Cotton, Gary Maartens : book review
The Oxford Handbook of HIV Medicine for Developing Countries is a long-overdue addition to the 'Oxford Handbook' series. It is… 
2002
2002
Availability of Hivid : letters
It has been brought to my attention that many HIV treating clinicians believe that zalcitabine (Hivid) has been taken off the… 
2000
2000
Zalcitabine (Hivid).
  • Research initiative, treatment action : RITA
  • 2000
  • Corpus ID: 36771574
1999
1999
What they say about nucleoside drugs.
Information on dosage, cost, side effects, and interactions is provided for each of the seven nucleoside analog drugs available… 
1996
1996
FDA Committee recommends clearance for HIVID combination therapy.
1996
1996
Saquinavir: combination shows survival benefit; new formulation trial recruiting.
On May 7, 1996, Hoffmann-La Roche released survival analysis of a major clinical trial comparing its protease inhibitor… 
1996
1996
Saquinavir prolongs survival and slows disease progression.
The Hoffmann-La Roche study, NV14256, showed that saquinavir (Invirase) and ddC (HIVID) reduced mortality by more than two… 
1995
1995
A consumer's guide to fighting HIV.
There are a range of options and common practices available for initiating anti-HIV therapies. The first-line treatment for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)